Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow



[
Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow
[og_img]
https://www.investing.com/news/stock-market-news/obesity-drugmaker-novo-nordisk-cuts-2025-outlook-posts-q1-profit-above-forecast-4027000


Reuters

Latest articles

spot_imgspot_img

Related articles

spot_imgspot_img